|
|
||||||||
Ludwig Institute for Cancer Research, Brussels Branch, and Cellular Genetics Unit, Université Catholique de Louvain, Brussels, Belgium
Murine mastocytoma P815 induces CTL responses against at least four distinct Ags (AB, C, D, and E). Recent studies have shown that the main component of the CTL response against the P815 tumor is targeted against Ags P815AB and P815E. The gene P1A has been well characterized. It encodes the P815AB Ag in the form of a nonameric peptide containing two epitopes, P815A and P815B, which are recognized by different CTLs. Here, we report the identification of the P815E Ag. Using a cDNA library derived from tumor P815, we identified the gene coding for P815E. We also characterized the antigenic peptide that anti-P815E CTLs recognize on the MHC class I molecule H-2Kd. The P815E Ag results from a mutation within an ubiquitously expressed gene encoding methionine sulfoxide reductase, an enzyme that is believed to be important in the protection of proteins against the by-products of aerobic metabolism. Surprisingly, immunizing mice i.p. with syngeneic tumor cells (L1210) that were constructed to express B7-1 and P815E did not induce resistance against live P815, even though a strong anti-P815E CTL response was observed with splenocytes from immunized animals.
This article has been cited by other articles:
![]() |
A. Shanker, G. Verdeil, M. Buferne, E.-M. Inderberg-Suso, D. Puthier, F. Joly, C. Nguyen, L. Leserman, N. Auphan-Anezin, and A.-M. Schmitt-Verhulst CD8 T Cell Help for Innate Antitumor Immunity J. Immunol., November 15, 2007; 179(10): 6651 - 6662. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Chen, T. Uno, and B. R. Ksander Tumor Escape Mutants Develop within an Immune-Privileged Environment in the Absence of T Cell Selection J. Immunol., July 1, 2006; 177(1): 162 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maia, W. N. Haining, S. Ansen, Z. Xia, S. A. Armstrong, N. P. Seth, P. Ghia, M. L. den Boer, R. Pieters, S. E. Sallan, et al. Gene Expression Profiling Identifies BAX-{delta} as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia Cancer Res., November 1, 2005; 65(21): 10050 - 10058. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tahara, K. Fujio, Y. Araki, K. Setoguchi, Y. Misaki, T. Kitamura, and K. Yamamoto Reconstitution of CD8+ T Cells by Retroviral Transfer of the TCR {alpha}{beta}-Chain Genes Isolated from a Clonally Expanded P815-Infiltrating Lymphocyte J. Immunol., August 15, 2003; 171(4): 2154 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Uenaka, Y. Hirano, H. Hata, S. Win, T. Aji, M. Tanaka, T. Ono, J. C. A. Skipper, K. Shimizu, and E. Nakayama Cryptic CTL Epitope on a Murine Sarcoma Meth A Generated by Exon Extension as a Novel Mechanism J. Immunol., May 1, 2003; 170(9): 4862 - 4868. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bilsborough, C. Uyttenhove, D. Colau, P. Bousso, C. Libert, B. Weynand, T. Boon, and B. J. Van den Eynde TNF-Mediated Toxicity After Massive Induction of Specific CD8+ T Cells Following Immunization of Mice with a Tumor-Specific Peptide J. Immunol., September 15, 2002; 169(6): 3053 - 3060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Markiewicz, F. Fallarino, A. Ashikari, and T. F. Gajewski Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A Int. Immunol., May 1, 2001; 13(5): 625 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bousso, F. Lemaitre, J. Bilsborough, and P. Kourilsky Facing Two T Cell Epitopes: A Degree of Randomness in the Primary Response Is Lost Upon Secondary Immunization J. Immunol., July 15, 2000; 165(2): 760 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. van Hall, J. van Bergen, P. A. van Veelen, M. Kraakman, L. C. Heukamp, F. Koning, C. J. M. Melief, F. Ossendorp, and R. Offringa Identification of a Novel Tumor-Specific CTL Epitope Presented by RMA, EL-4, and MBL-2 Lymphomas Reveals Their Common Origin J. Immunol., July 15, 2000; 165(2): 869 - 877. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |